10-Q Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001493152-21-019738`
Period End Date	20210630
Filing Date	20210813
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 59 Cash Flow Statement 61 Stockholders Equity 41

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Cash	`Cash`	$20.62M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	3.28M	shares	Point-in-time
Cash	`Cash`	$1.58M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$700.71K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$891.47K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	3.28M	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current assets	`AssetsCurrent`	$21.51M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.28M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.82M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.19M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.10M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	21.43M	shares	Point-in-time
Total assets	`Assets`	$23.69M	USD	Point-in-time
Total assets	`Assets`	$4.10M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.10M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	21.43M	shares	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$681.25K	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$1.02M	USD	Point-in-time
Current portion of loans payable	`LoansPayableCurrent`	-	USD	Point-in-time
Current portion of loans payable	`LoansPayableCurrent`	$148.60K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.17M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$681.25K	USD	Point-in-time
Warrant liability	`WarrantLiabilitiesNoncurrent`	$3.71M	USD	Point-in-time
Warrant liability	`WarrantLiabilitiesNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$4.88M	USD	Point-in-time
Total liabilities	`Liabilities`	$681.25K	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred Stock, $0.01 par value, 20,000,000 shares authorized, 0 and 3,275,407 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $0.01 par value, 20,000,000 shares authorized, 0 and 3,275,407 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`PreferredStockValue`	$32.75K	USD	Point-in-time
Common stock, $0.01 par value, 100,000,000 shares authorized, 21,432,415 and 10,095,109 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$214.33K	USD	Point-in-time
Common stock, $0.01 par value, 100,000,000 shares authorized, 21,432,415 and 10,095,109 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$100.95K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$15.22M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$34.70M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.76M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-15.92M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-178.80K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-181.28K	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$-3.48M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$18.99M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$3.42M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$-2.70M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$-1.81M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$18.82M	USD	Point-in-time
Total Liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$23.69M	USD	Point-in-time
Total Liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$4.10M	USD	Point-in-time

Income Statement 59 line items

Line Item	Tag	Value	Unit	Period
Research and development costs	`ResearchAndDevelopmentExpense`	$879.84K	USD	1 Quarter
Research and development costs	`ResearchAndDevelopmentExpense`	$70.96K	USD	2 Qtrs
Research and development costs	`ResearchAndDevelopmentExpense`	$1.08M	USD	2 Qtrs
Research and development costs	`ResearchAndDevelopmentExpense`	$50.96K	USD	1 Quarter
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.31M	USD	1 Quarter
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.53M	USD	2 Qtrs
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$8.74M	USD	2 Qtrs
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$716.55K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	-	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$310.66K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	-	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$174.02K	USD	1 Quarter
Total operating expenses	`OperatingCostsAndExpenses`	$3.36M	USD	1 Quarter
Total operating expenses	`OperatingCostsAndExpenses`	$767.51K	USD	1 Quarter
Total operating expenses	`OperatingCostsAndExpenses`	$10.13M	USD	2 Qtrs
Total operating expenses	`OperatingCostsAndExpenses`	$1.60M	USD	2 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-10.13M	USD	2 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-1.60M	USD	2 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-767.51K	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-3.36M	USD	1 Quarter
Interest expense	`InterestExpense`	$312.64K	USD	2 Qtrs
Interest expense	`InterestExpense`	$50.88K	USD	1 Quarter
Interest expense	`InterestExpense`	$4.82K	USD	1 Quarter
Interest expense	`InterestExpense`	$4.82K	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-2.46M	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-6.27M	USD	2 Qtrs
Inducement expense	`InducementExpense`	-	USD	1 Quarter
Inducement expense	`InducementExpense`	$298.71K	USD	2 Qtrs
Inducement expense	`InducementExpense`	-	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-50.88K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$5.97M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-312.64K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$2.45M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-908.29K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.10M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-818.39K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.25M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.92M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-4.16M	USD	2 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$35.74K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-10.07K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-33.26K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.47K	USD	2 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-22.77K	USD	2 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-12.70K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.16M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-941.55K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-828.46K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.94M	USD	2 Qtrs
Net loss per share basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
Net loss per share basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	2 Qtrs
Net loss per share basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	1 Quarter
Net loss per share basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	2 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	18.69M	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	21.33M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.67M	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.67M	shares	1 Quarter

Cash Flow Statement 61 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-908.29K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.10M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-818.39K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.25M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.92M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.16M	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$249.57K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	2 Qtrs
Accrued interest	`AccruedInterest`	$59.87K	USD	2 Qtrs
Accrued interest	`AccruedInterest`	-	USD	2 Qtrs
Change in fair value of warrant derivatives	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant derivatives	`FairValueAdjustmentOfWarrants`	$-2.46M	USD	1 Quarter
Change in fair value of warrant derivatives	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Change in fair value of warrant derivatives	`FairValueAdjustmentOfWarrants`	$-6.27M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$4.34M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	-	USD	2 Qtrs
Inducement expense	`GainsLossesOnInducementExpense`	-	USD	2 Qtrs
Inducement expense	`GainsLossesOnInducementExpense`	$-298.71K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	-	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$310.66K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	-	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$174.02K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$190.76K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$52.12K	USD	2 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities`	$414.47K	USD	2 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities`	$486.27K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.25M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.18M	USD	2 Qtrs
Purchase of Diverse Bio license agreement	`PaymentsToAcquireIntangibleAssets`	$675.00K	USD	2 Qtrs
Purchase of Diverse Bio license agreement	`PaymentsToAcquireIntangibleAssets`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-675.00K	USD	2 Qtrs
Proceeds from sale of common stock and warrants, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$21.61M	USD	2 Qtrs
Proceeds from sale of common stock and warrants, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from convertible notes payable	`ProceedsFromConvertibleDebt`	$50.00K	USD	2 Qtrs
Proceeds from convertible notes payable	`ProceedsFromConvertibleDebt`	-	USD	2 Qtrs
Proceeds from note payable	`ProceedsFromNotesPayable`	-	USD	2 Qtrs
Proceeds from note payable	`ProceedsFromNotesPayable`	$1.81M	USD	2 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$157.71K	USD	2 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	-	USD	2 Qtrs
Proceeds from warrant exercises	`ProceedsFromWarrantExercise`	$3.29M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.70M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$24.90M	USD	2 Qtrs
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-61.96K	USD	2 Qtrs
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-1.05K	USD	2 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$397.68K	USD	2 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$19.04M	USD	2 Qtrs
Cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$20.62M	USD	Point-in-time
Cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$441.39K	USD	Point-in-time
Cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.58M	USD	Point-in-time
Cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$43.71K	USD	Point-in-time
Cash - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$20.62M	USD	Point-in-time
Cash - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$441.39K	USD	Point-in-time
Cash - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.58M	USD	Point-in-time
Cash - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$43.71K	USD	Point-in-time
Beneficial conversion feature issued with note payable	`BeneficialConversionFeatureIssuedWithNotePayable`	-	USD	2 Qtrs
Beneficial conversion feature issued with note payable	`BeneficialConversionFeatureIssuedWithNotePayable`	$17.85K	USD	2 Qtrs
Warrants issued in conjunction with notes payable issuances	`WarrantsIssuedInConjunctionWithNotesPayable`	$32.15K	USD	2 Qtrs
Warrants issued in conjunction with notes payable issuances	`WarrantsIssuedInConjunctionWithNotesPayable`	-	USD	2 Qtrs
Shares of common stock issued for accounts payable	`StockIssued1`	$173.48K	USD	2 Qtrs
Shares of common stock issued for accounts payable	`StockIssued1`	-	USD	2 Qtrs

Stockholders Equity 41 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$-3.48M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$18.99M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$3.42M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-2.70M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-1.81M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$18.82M	USD	Point-in-time
Common stock issued for accounts payable	`StockIssuedDuringPeriodValueCommonStockIssuedForAccountsPayable`	$173.48K	USD	1 Quarter
Warrants issued in conjunction with notes payable	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$32.15K	USD	1 Quarter
Beneficial conversion feature issued with note payable	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$17.85K	USD	1 Quarter
Common stock issued in conjunction with not payable modification	`StockIssuedDuringPeriodValueCommonStockIssuedInConjunctionWithNotPayableModification`	$45.73K	USD	1 Quarter
January 2021 registered direct offering	`StockIssuedDuringPeriodValueIssuedDirectOffering`	$4.62M	USD	1 Quarter
February 2021 registered direct offering	`StockIssuedDuringPeriodValueIssuedDirectOfferingOne`	$7.02M	USD	1 Quarter
Stock based compensation	`StockGrantedDuringPeriodValueSharebasedCompensationGross`	$3.59M	USD	1 Quarter
Stock based compensation	`StockGrantedDuringPeriodValueSharebasedCompensationGross`	$750.93K	USD	1 Quarter
Induced conversion of stock options into restricted stock awards	`AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium`	$298.71K	USD	1 Quarter
Conversion of Series B Preferred Stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Conversion of stock options into restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Conversion of stock options into restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$6.97M	USD	2 Qtrs
Conversion of stock options into restricted stock, shares	`StockIssuedDuringPeriodSharesRestrictedStockAwardGross`	525,000.00	shares	Point-in-time
Exercise of warrants	`ExerciseOfWarrants`	$17.93K	USD	1 Quarter
Exercise of warrants	`ExerciseOfWarrants`	$3.27M	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	-	USD	1 Quarter
Exercise of options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	143,796.00	shares	2 Qtrs
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$35.74K	USD	1 Quarter
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-10.07K	USD	1 Quarter
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-33.26K	USD	1 Quarter
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.47K	USD	2 Qtrs
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-22.77K	USD	2 Qtrs
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-12.70K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-908.29K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.10M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-818.39K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.25M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.92M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.16M	USD	2 Qtrs
Ending balance, value	`StockholdersEquity`	$-3.48M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$18.99M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$3.42M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-2.70M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-1.81M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$18.82M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.